|
Cefoxitin
|
D03.633.100.300.249.250.222 |
|
|
Self-Management
|
D000073278 |
[Individual's ability to manage the symptoms, treatment, physical and psychosocial consequences and lifestyle changes inherent in living with a chronic condition. Efficacious self-management encompasses ability to monitor one's condition and to affect the cognitive, behavioral, and emotional responses necessary to maintain a satisfactory quality of life.
] |
|
Lesch-Nyhan Syndrome
|
C18.452.648.189.425 |
|
|
Decalcification, Pathologic
|
C18.452.104.247.400 |
|
|
Bone Demineralization, Pathologic
|
C18.452.104.247 |
|
|
Melanocortins
|
D06.472.699.631.525.600.531 |
|
|
Maternal Age
|
N05.715.350.075.550 |
|
|
Age Factors
|
N05.715.350.075 |
|
|
Leukocyte Elastase
|
D08.811.277.656.959.350.560.500 |
|
|
Reactive Oxygen Species
|
D01.650.775 |
|
|
Oxygen Compounds
|
D01.650 |
|
|
Kallikreins
|
D23.119.597 |
|
|
Fontan Procedure
|
E04.100.376.724.500 |
|
|
Tannins
|
D05.750.078.937 |
|
|
Biopolymers
|
D05.750.078 |
|
|
Retinal Telangiectasis
|
C11.768.748 |
|
|
Auditory Perceptual Disorders
|
C10.228.140.068.094 |
|
|
Darier Disease
|
C17.800.827.190 |
|
|
Sickle Cell Trait
|
D012805 |
[The condition of being heterozygous for hemoglobin S.
] |
|
Synovial Fluid
|
A02.835.583.443.800.800 |
|
